News

The A-FLUX Reducer System from VahatiCor is designed to treat coronary microvascular dysfunction.

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Impella users need to monitor for blood leaks at the sidearm and hub of the introducer sheath shown below here introducers.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Devi Nair, MD, director of electrophysiology and research at St. Bernards Medical Center and the Arrhythmia Research Group, explains new technology advances in leadless pacing for conduction pacing and Bachmann's bundle pacing.

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.

 

Midjourney ultrasound scanning whole-body ultrasonic CT

Radiologists, meanwhile, took to social media to criticize the endeavor, noting that the generative AI company lacks clinical evidence to back its marketing claims. 

The proportion of radiologists performing some (>0%) IR-related work declined from 70% in 2008 down to 50% by 2023, according to new research published in JVIR. 

lung cancer screening low-dose CT

While overall lung cancer rates are declining, cases among nonsmoking women are on the rise, puzzling scientists.   

family in supermarket

One of the largest food retailers in the world—and the fourth biggest in this country—got itself into hot water with the U.S. Department of Justice for allegedly cheating on drug prices it charges to federal healthcare programs.

legal liability malpractice artificial intelligence

Tamin Naber, MD, was charged with simple assault for biting a former employee at his medical practice who was suing him for wrongful termination. The incident occurred in November 2025. 

Thumbnail

The U.S. Department of Justice said the settlement will save citizens of the state money and open up the market to competition.

nursing home elderly patient

Either the stakeholders issuing the warnings overstated the risk of widespread closings—or COVID-era emergency funds succeeded in heading off a calamity of national proportions. Either way, patient access has taken a hit here and there.  

Thumbnail

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

Siemens Healthineers invests $30M into new radiopharma facility

The new site will have up to eight times the manufacturing capacity of any other radiopharmaceutical facility. 

Around the web

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.